Patrick A Forcelli Selected Research

Patrick A Forcelli Research Topics

Disease

22	Seizures (Absence Seizure) 02/2021 - 04/2011
11	Epilepsy (Aura) 10/2020 - 07/2010
1	Generalized Epilepsy 10/2020
1	Dementia (Dementias) 04/2020
1	Cognitive Dysfunction 04/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2018
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018
1	Partial Epilepsies (Epilepsy, Partial) 01/2018
1	Hypoxia (Hypoxemia) 01/2018
1	Epileptic Syndromes 01/2017
1	Teratogenesis 04/2016
1	Blepharoptosis (Ptosis, Eyelid) 02/2016
1	Mood Disorders (Mood Disorder) 02/2016
1	Depressive Disorder (Melancholia) 02/2016
1	Hemorrhage 01/2016
1	Brain Hypoxia-Ischemia (Hypoxia Ischemia, Brain) 01/2016
1	Parkinson Disease (Parkinson's Disease) 04/2015
1	Autism Spectrum Disorder 02/2015
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 05/2014
1	Tobacco Use Disorder (Nicotine Dependence) 05/2014
1	Weight Gain 05/2014
1	Torticollis (Wryneck) 04/2013
1	Dyskinesias (Dyskinesia) 04/2013
1	Dystonia (Limb Dystonia) 09/2012
1	Shock 05/2007

Drug/Important Bio-Agent (IBA)

9	Anticonvulsants (Antiepileptic Drugs)IBA 02/2021 - 08/2012
9	Phenobarbital (Luminal)FDA Link 01/2019 - 07/2010
8	Pharmaceutical PreparationsIBA 10/2020 - 12/2013
7	Pentylenetetrazole (Metrazol)IBA 12/2019 - 04/2011
5	methyl 6,7- dimethoxy- 4- ethyl- beta- carboline- 3- carboxylateIBA 02/2021 - 10/2014
3	4-Butyrolactone (gamma Butyrolactone)IBA 12/2019 - 03/2016
2	Losartan (Cozaar)FDA LinkGeneric 04/2020 - 01/2018
2	Levetiracetam (Keppra)FDA LinkGeneric 01/2018 - 11/2014
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2014
2	Tiagabine (Gabitril)FDA Link 01/2018 - 11/2014
2	ezogabine (retigabine)IBA 04/2016 - 08/2012
2	MuscimolIBA 04/2013 - 09/2012
1	perampanelIBA 02/2021
1	brivaracetamIBA 02/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2020
1	Hormones (Hormone)IBA 10/2020
1	Type 1 Angiotensin ReceptorIBA 04/2020
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 01/2020
1	1-ethyl-2-benzimidazolinoneIBA 01/2020
1	Small-Conductance Calcium-Activated Potassium Channels (SK Potassium Channels)IBA 01/2020
1	PotassiumIBA 01/2020
1	3- (2- hydroxy- 4- (1,1- dimethylheptyl)phenyl)- 4- (3- hydroxypropyl)cyclohexanolIBA 01/2020
1	CalciumIBA 01/2020
1	ParvalbuminsIBA 01/2020
1	cannabidivarinIBA 01/2019
1	Peptide Hydrolases (Proteases)FDA Link 11/2018
1	LigandsIBA 11/2018
1	Matrix Metalloproteinase 1 (Interstitial Collagenase)IBA 11/2018
1	Isoflurane FDA LinkGeneric 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Adenosine (Adenocard)FDA LinkGeneric 01/2018
1	AlbuminsIBA 01/2018
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2017
1	Cannabinoid Receptor AgonistsIBA 01/2017
1	CannabinoidsIBA 01/2017
1	MecamylamineIBA 02/2016
1	Methadone (Dolophine)FDA LinkGeneric 02/2016
1	Designer DrugsIBA 01/2016
1	SynucleinsIBA 04/2015
1	EphrinsIBA 02/2015
1	norharmanIBA 10/2014
1	Anti-Anxiety Agents (Anxiolytics)IBA 05/2014
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 05/2014
1	Nicotine FDA Link 05/2014
1	sazetidine-AIBA 05/2014
1	PlasticsIBA 01/2014
1	MelatoninIBA 12/2013
1	imidazole mustard (BIC)IBA 04/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Phenytoin (Dilantin)FDA LinkGeneric 12/2011
1	Lamotrigine (Lamictal)FDA LinkGeneric 04/2011
1	NeuropeptidesIBA 05/2007
1	CorticosteroneIBA 05/2007
1	Corticotropin-Releasing HormoneIBA 05/2007

Therapy/Procedure

7	Therapeutics 10/2020 - 07/2010
3	Drug Therapy (Chemotherapy) 10/2020 - 02/2016
1	Ovariectomy (Oophorectomy) 04/2020
1	Topical Administration 01/2018
1	Craniotomy 01/2013
1	Electrodes (Electrode) 01/2013